It supports tissue repair by activating genes involved in collagen and elastin synthesis, regulating inflammatory pathways, promoting angiogenesis, and improving cellular regeneration
Semaglutide 2.4 mg earned FDA approval for chronic weight management in June 2021 based on the STEP-1 trial (N=1,961), which demonstrated 14.9% mean body weight reduction at 68 weeks versus 2.4% with placebo [1]
What Patients Should Ask Before Starting Any GLP-1 or Peptide-Based Weight-Loss Plan Before starting a GLP-1 medication, peptide therapy, or any online product marketed for weight loss, patients should ask: Is this medication FDA-approved or investigational
Sichuan Hantong Kuntai was established in 2025
You typically start with a 0.25 mg dose of semaglutide and B12, and your doctor may adjust the dose to 0.5 mg based on your needs
Why Choose Our Medical Weight Loss Program